Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe + Simvastatin in Korean Patients with Primary Hypercholesterolemia
NCT00157911Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Dec 2002
- Primary completion
- Oct 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Low Density Lipoprotein Cholesterol at 12 weeks. Started Dec 2002; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00157911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157911.